Zomedica Corp. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Zomedica Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2017 to Q3 2024.
  • Zomedica Corp. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $473K, a 71.6% decline year-over-year.
  • Zomedica Corp. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.54M, a 46.4% decline year-over-year.
  • Zomedica Corp. annual Share-based Payment Arrangement, Expense for 2023 was $6.26M, a 20.6% decline from 2022.
  • Zomedica Corp. annual Share-based Payment Arrangement, Expense for 2022 was $7.89M, a 11.3% increase from 2021.
  • Zomedica Corp. annual Share-based Payment Arrangement, Expense for 2021 was $7.09M, a 328% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.54M $473K -$1.2M -71.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.73M $859K -$866K -50.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $5.6M $1.1M -$664K -37.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $6.26M $1.11M -$333K -23.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $6.6M $1.67M -$252K -13.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $6.85M $1.73M -$767K -30.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $7.62M $1.77M -$276K -13.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $7.89M $1.44M -$1.15M -44.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $9.04M $1.92M +$482K +33.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $8.56M $2.49M +$710K +39.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $7.85M $2.04M +$758K +59.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $7.09M $2.59M +$1.41M +120% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $5.68M $1.44M +$1.25M +665% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $4.43M $1.78M +$1.65M +1212% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $2.78M $1.28M +$1.13M +728% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.66M $1.18M +$1.18M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $479K $188K -$10K -5.06% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $489K $136K +$136K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $353K $155K -$2.19M -93.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $2.54M $0 $0 Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $2.54M $198K +$198K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $2.34M $0 -$1.6K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $2.34M $2.34M +$2.34M +41037% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $7.29K $0 Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 $0 -$676K -100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.6K* +$1.6K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $5.69K Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-15
Q3 2017 $676K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.